Alli chewable tablet due out this spring
GlaxoSmithKline has received a license extension to market a chewable tablet version of its weight-loss aid alli in Europe. GSK said Monday that the new alli chewable tablets (orlistat 27 mg) are slated to go on sale in pharmacies throughout the United Kingdom in April.